Development of a CP 31P NMR broadline simulation methodology for studying the interactions of antihypertensive AT1 antagonist losartan with phospholipid bilayers

Biophysical Journal

Volumn 96, Issue 6, 2009, Pages 2227-2236

  Fotakis, Charalambos ^a   Christodouleas, Dionisios ^a   Chatzigeorgiou, Petros ^a   Zervou, Maria ^b   Benetis, Nikolas Ploutarch ^b   Viras, Kyriakos ^a   Mavromoustakos, Thomas ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CARBON 13; DIPALMITOYLPHOSPHATIDYLCHOLINE; LOSARTAN; PHOSPHORUS 31; ANGIOTENSIN RECEPTOR ANTAGONIST; CARBON; PHOSPHORUS;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIFFERENTIAL SCANNING CALORIMETRY; ELECTRON SPIN RESONANCE; LIQUID CRYSTAL; PHOSPHOLIPID BILAYER; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; POLARIZATION; RAMAN SPECTROMETRY; SIMULATION; ANISOTROPY; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; LIPID BILAYER; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE; TEMPERATURE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANISOTROPY; CALORIMETRY, DIFFERENTIAL SCANNING; CARBON ISOTOPES; COMPUTER SIMULATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; LIPID BILAYERS; LOSARTAN; MODELS, CHEMICAL; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHORUS ISOTOPES; SPECTRUM ANALYSIS, RAMAN; TEMPERATURE;

EID: 66149098533     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2008.11.057     Document Type: Article

References (35)

1. Mavromoustakos, T., A. Kolocouris, M. Zervou, P. Roumelioti, J. Matsoukas, et al. 1999. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations. J. Med. Chem. 42:1714-1722.
2. Zoumpoulakis, P., S. G. Grdadolnik, J. Matsoukas, and T. Mavromoustakos. 2002. Structure elucidation and conformational properties of eprosartan, a non peptide angiotensin II AT1 antagonist. J. Pharm. Biomed. Anal. 28:125-135.
3. 1 antagonists. Stereoelectronic requirements for antihypertensive efficacy. J. Pharm. Biomed. Anal. 31:833-844.
4. Moutevelis-Minakakis, P., M. Gianni, H. Stougiannou, P. Zoumpoulakis, A. Zoga, et al. 2003. Design and synthesis of novel antihypertensive drugs. Bioorg. Med. Chem. Let. 13:1737-1740.
5. 1 antagonist. J. Pharm. Biomed. Anal. 40:1097-1104.
6. Mavromoustakos, T., P. Moutevelis-Minakakis, C. G. Kokotos, P. Kontogianni, A. Politi, et al. 2006. Synthesis, binding studies, and in vivo biological evaluation of novel non-peptide antihypertensive analogs. Bioorg. Med. Chem. 14:4353-4360.
7. 31P CP NMR multilamellar bilayer broadlines in the absence and presence of the Bioactive Dipeptide β-Ala-Tyr or Glu. Chem. Phys. 314:57-72.
8. 31P NMR line shapes of lipid bilayers using an analytically soluble model. Solid State Nucl. Magn. Reson. 24:1-22.
9. 31P nuclear magnetic resonance chemical shielding tensor. Biochemistry. 16:519-526.
10. Orädd, G., and G. Lindblom. 2004. Lateral diffusion studied by pulsed field gradient NMR on oriented lipid membranes. Magn. Reson. Chem. 42:123-131.
11. Houslay, M. D., and K. K. Stanley. 1982. Dynamics of Biological Membranes. John Wiley & Sons, New York.
12. 31P nuclear magnetic resonance of phospholipids. Biophys. J. 48:547-552.
13. De Casparo, M., K. J. Catt, T. Inagami, J. W. Wright, and T. Unger. 2000. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52:415-472.
14. Sakarellos, C., K. Lintner, F. Piriou, and S. Fermandjian. 1983. Conformation of the central sequence of angiotensin II and analogues. Biopolymers. 22:663-687.
15. Zoumpoulakis, P., I. Daliani, M. Zervou, I. Kyrikou, E. Siapi, et al. 2003. Losartan's molecular basis of interaction with membranes and AT1 receptor. Chem. Phys. Lipids. 125:13-25.
16. Matsoukas, J., G. Agelis, A. Wahhab, J. Hondrelis, D. Panagiotopoulos, et al. 1995. Differences in backbone structure between angiotensin II agonists and type I antagonists. J. Med. Chem. 38:4660-4669.
17. Theodoropoulou, E., and D. Marsh. 1999. Interactions of angiotensin II non-peptide AT1 antagonist losartan with phospholopid membranes studied by combined use of differential scanning calorimetry and electron spin resonance spectroscopy. Biochim. Biophys. Acta. 1461:135-146.
18. 13C-NMR studies. Biochim. Biophys. Acta. 1026:225-235.
19. Press, W. H., B. P. Flannery, S. A. Teukolsky, and W. T. Vetterling. Numerical Recipes. 1986. The Art of Scientific Computing. Cambridge University Press, Cambridge, UK.
20. Kyrikou, I., N.-P. Benetis, P. Chatzigeorgiou, M. Zervou, K. Viras, et al. 2008. Interactions of the dipeptide paralysin β-Ala-Tyr and the aminoacid Glu with phospholipids bilayers. Biochim. Biophys. Acta. 1778:113-124.
21. Halle, B., and H. Wennerström. 1981. Interpretation of magnetic resonance data from water nuclei in heterogeneous systems. J. Chem. Phys. 75:1928-1943.
22. Leach, A. R. 2001. Molecular Modelling. Principles and Applications, 2nd ed. Prentice-Hall, Harlow, England.
23. Maswadeh, H., C. Demetzos, I. Daliani, I. Kyrikou, T. Mavromoustakos, et al. 2002. A molecular basis explanation of the dynamic and thermal effects of vinblastine sulfate upon dipalmitoylphosphatidylcholine bilayer membranes. Biochim. Biophys. Acta. 1567:49-55.
24. Kyrikou, I., I. Daliani, T. Mavromoustakos, H. Maswadeh, C. Demetzos, et al. 2004. The modulation of thermal and dynamic properties of vinblastine by cholesterol in membrane bilayers. Biochim. Biophys. Acta. 1661:1-8.
25. Dopico, A. M. 2007. Methods in Membrane Lipids. Humana Press.
26. 2H-NMR study. Biochim. Biophys. Acta. 1106: 317-324.
27. Lawson, K. D., and T. J. Flautt. 1967. Magnetically oriented lyotropic liquid crystalline phases. J. Am. Chem. Soc. 89:5489-5491.
28. 31P Nuclear magnetic resonance chemical shielding tensor of phosphorylethanolamine, lecithin, and related compounds: application to head-group motion in modern membranes. Biochemistry. 15:967-973.
29. 31P angular dependent nuclear spin relaxation time study. Biophys. J. 56:543-549.
30. Huang, C. -h., J. R. Lapides, and I. W. Levin. 1982. Phase-transition Behavior of Saturated, Symmetric Chain Phospholipid Bilayer Dispersions Determined by Raman Spectroscopy: Correlation between Spectral and Thermodynamic Parameters. J. Am. Chem. Soc. 104:5926-5930.
31. O' Leary, T. J., and I. W. Levin. 1984. Raman spectroscopic study of the melting behavior of anhydrous dipalmitoylphosphatidylcholine bilayers. J. Phys. Chem. 88:1790-1796.
32. O' Leary, T. J., and I. W. Levin. 1984. Raman spectroscopic study of an interdigitated lipid bilayer dipalmitoylphosphatidylcholine dispersed in glycerol. Biochim. Biophys. Acta. 776:185-189.
33. Hsu, J. C. Y., and C. M. Yip. 2007. Molecular dynamics simulations of indolicdin association with model lipid bilayers. Biophys J. BioFAST. L01-L03.
34. Mavromoustakos, T., P. Zoumpoulakis, I. Kyrikou, A. Zoga, E. Siapi, et al. 2004. Efforts to understand molecular basis of hypertension through drug: membrane interactions. Curr. Top. Med. Chem. 4:445-459.
35. Mavromoustakos, T., M. Zervou, P. Zoumpoulakis, I. Kyrikou, N. P. Benetis, et al. 2004. Conformation and bioactivity. design and discovery of novel antihypertensive drugs. Curr. Top. Med. Chem. 4:385-401.